PwC Welcomes Medi2data to Scale | InsurTech 2025

Share This Post

Medi2data Join PwC’s Prestigious Scale | InsurTech Programme for 2025

We are delighted to announce that Medi2data have been selected as part of the PwC Scale | InsurTech Programme cohort for 2025! Having been selected from a competitive pool of over 800+ businesses, we’re thrilled to be part of this initiative. With this year’s focus highlighting the Life, Retirement, and Wealth sectors, being part of the cohort reinforces our commitment to driving digital transformation within the Insurance industry and providing cutting-edge solutions to our enterprise clients. 

We’re are proud to join an esteemed group of InsurTech innovators, including:

  • Abbove
  • Delta Financial Systems
  • Planworth
  • ProposalAI
  • QPLIX
  • Qantev
  • WealthObjects

By being part of this cohort, we are working together to represent the future of digital transformation in insurance by leveraging technology to enhance decision-making, streamline processes, and improve customer experiences.

A landmark opportunity for growth and collaboration

PwC’s Scale | InsurTech Programme is designed to accelerate high-potential InsurTech companies by providing them with direct access to PwC’s vast network and leading industry players. As part of the programme, Medi2data will collaborate with top executives, investors, and decision makers in the insurance sector to discuss our service offerings and propositions. 

Throughout the programme, we will benefit from expert-led sessions covering essential business areas such as: 

  • Sales and marketing
  • Operational scalability
  • Fundraising
  • Leadership in high-growth environments. 

This structured support is invaluable in enhancing our market positioning and expanding our reach within the insurance ecosystem.

Driving change in the insurance sector

Since our early beginnings in 2017, Medi2data has been at the forefront of medical data innovation. Initially developed to facilitate the electronic transaction of third-party medical reports and Subject to Access Requests (SARs) for GP practices, Medi2data has since expanded its offerings. Today, we provide an advanced suite of services (including eMR, eMR+, OMEG, Clinical Triage, and CMO Review) designed to enhance access to consented and curated medical data.

Our team operates across Cardiff, London, and Cape Town to help empower clients by delivering fast and accurate medical data, and streamlining both decision-making processes and customer journeys. With our proprietary technology and clinically led governance framework, we can ensure that all of our clients receive high-quality, reliable data while reducing inefficiencies and operational costs.

A testament to excellence

Nick Freeman, Chief Commercial Officer at Medi2data comments on the programme:

We’d like to extend our gratitude to PwC and their selection panel for including us in this year’s Scale | InsurTech cohort. Not only does this programme help to propel Medi2data’s services to a wider audience, it’s also a testament to the hard work our team do to provide market-leading services to our enterprise clients. 

As we navigate this new experience with PwC and our fellow cohort members, we remain dedicated to our mission – powering access to consented and curated medical data. The future of InsurTech is on the way, and we’re proud to be involved in paving it. 

Want more information on our market-leading services for the insurance sector? Get in touch.

Find out more about the Scale | InsurTech Programme.

More To Explore